Loading...

News List

News List

Journey Medical's rosacea drug Emrosi is approved by the FDA

On November 4, Journey Medical announced that the FDA has approved Emrosi™ (Minocycline hydrochlorid

READ MORE 2024-11-06
Roche has released new clinical data showing that monoclonal antibodies sustainably slow the progression of Parkinson's disease

Recently, Roche (Roche) researchers published in the international top medical journal Nature Medici

READ MORE 2024-10-19
Copd lung disease breakthrough! Successful Phase III study of GSK Mepolizumab

On September 6, GlaxoSmithKline (GSK) announced positive results from the Phase III MATINEE study of

READ MORE 2024-09-10
My first! The GSK RSV vaccine has been approved by the FDA to be extended to age 50-59

On June 7, GlaxoSmithKline (GSK) announced that the FDA approved Arexvy, a recombinant respiratory s

READ MORE 2024-06-12
Over $2 billion! Takeda introduces an anti-Aβ vaccine

On May 13, Takeda announced that it has entered into A worldwide exclusive option and license agreem

READ MORE 2024-05-17
Astrazeneca's "first-in-class" oral small molecule is approved by the FDA

On April 1, 2024, Astrazeneca announced the FDA approval of its "first-in-class" oral smal

READ MORE 2024-04-24
Nature Biotechnology | Antibody Drug Conjugators (ADCs) : ushering in a new era of precision cancer therapy

Recent studies have shown that by improving the linking technology and developing novel drug carrier

READ MORE 2024-03-15
The oral version of Semaglutide was approved for domestic market, and clinical results showed that it can effectively reduce blood sugar and lose weight

On January 26, 2024, the official website of the State Food and Drug Administration showed that the

READ MORE 2024-02-06
Semaglutide has a real rival! Lilly's strongest weight-loss drug, tilpotide is approved by the FDA

The FDA approved Tizepatide, developed by Eli Lilly and Company, as a weight loss drug (trade name Z

READ MORE 2023-11-30
It can restore 80% hair growth, and Pfizer's new drug for alopecia areata was approved for sale in China, which can treat adolescent alopecia areata
It can restore 80% hair growth, and Pfizer's new drug for alopecia areata was approved for sale in China, which can treat adolescent alopecia areata

On October 19, 2023, the official website of China's State Drug Administration showed that it ap

READ MORE 2023-11-01